Morris, James Culvin
- Clemson University (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,941
- Rising Star
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#1,941
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Morris, James Culvin as a PI. Multi-PI records show the full award amount for context.
- $2.2Maward amount
- 3P20GM146584-02S1P20Contact PIAcquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University$296.1Kaward amount
- 1R21AI171217-01A1R21Contact PIEnolase inhibitors as therapeutic leads for Naegleria fowleri infections$205.4Kaward amount
- 1R21AI175463-01R21Contact PIApproaches for genetic manipulation of Naegleria fowleri$190.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Morris, James Culvin as a PI.
FY2023 award administered by Clemson University (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardClemson University
- 2012$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #3053
- 2022Entered Top 25% NationallyRanked #3053
- 2023$5M Cumulative Funding
- 2023Entered Top 10% NationallyRanked #1941